REG-The Biotech Growth Trust PLC: Transaction in Own Shares

Biotech Growth TrustAnnouncement

21/02/2025 17:30

For immediate release

21 February 2025

 
THE BIOTECH GROWTH TRUST PLC
(the "Company")

 

 

MARKET PURCHASE OF COMPANY'S OWN SHARES

 

 

 

Notification is given, pursuant to the authority granted at the Annual General
Meeting of the Company held on 18 July 2024 to make market purchases of the
Company's own shares up to an aggregate maximum of 4,929,790 that a market
total of 111,879 Ordinary shares of 25p each in the capital of the Company
were purchased today for cancellation by the Company at a price of 841.81
pence per share.

 

Following this transaction, the Company hereby notifies the market that the
total number of Ordinary shares that the Company has in issue, less the total
number of Ordinary shares bought back for cancellation by the Company
following such purchase, and therefore, the total number of voting rights in
the Company is 28,387,591. The Company does not currently hold any Ordinary
shares in treasury.

 

The figure of 28,387,591 may be used by shareholders as the denominator for
the calculation by which they may determine if they are required to notify
their interest in, or change to their interest in, the Company under the FCA's
Disclosure Guidance and Transparency Rules.

 
For and on behalf of
Frostrow Capital LLP

Company Secretary

 

For further information, please contact:

 

Katherine Manson

Frostrow Capital LLP

Tel: 020 3709 8734



Copyright (c) 2025 PR Newswire Association,LLC. All Rights Reserved